All In Biotech

Drug Trial Radar · NCT07262476

Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

A Phase III, Multicenter, Open-Label Extension Study to Evaluate the Efficacy and Safety of MHB018A Injection in Subjects With Thyroid Eye Disease

Last checked: Nov 19, 2026Latest source record: Mar 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

258

Planned (sponsor's estimate)

Start

Jan 9, 2026

Primary completion

Jan 31, 2029

Study completion Jan 31, 2030

Sponsor

Sponsor type
Industry
First posted
Dec 3, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multicenter, open-label extension (OLE) study of MHB018A in subjects with moderate-to-severe TED.

Conditions

  • Thyroid Eye Disease (TED)

Interventions

  • MHB018A injectionDrug

    MHB018A 450mg for subcutaneous injection once every 4 weeks (Q4W)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proptosis Responder Rate at Week 24Time frame: Week 24

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine

    Shanghai, Shanghai Municipality, China · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.